- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Voyager Therapeutics is a biotechnology business based in the US. Voyager Therapeutics shares (VYGR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.75 – a decrease of 8.29% over the previous week. Voyager Therapeutics employs 162 staff and has a trailing 12-month revenue of around $163.8 million.
What's in this guide?
Our top picks for where to buy Voyager Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Voyager Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VYGR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Voyager Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Voyager Therapeutics stock price (NASDAQ: VYGR)
Use our graph to track the performance of VYGR stocks over time.Voyager Therapeutics shares at a glance
Information last updated 2024-12-19.
| Latest market close | $5.75 |
|---|---|
| 52-week range | $5.19 - $11.72 |
| 50-day moving average | $6.59 |
| 200-day moving average | $7.62 |
| Wall St. target price | $17.10 |
| PE ratio | 8.7727 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.66 |
Is it a good time to buy Voyager Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Voyager Therapeutics price performance over time
Historical closes compared with the close of $5.69 from 2024-12-19
| 1 week (2024-12-13) | -9.25% |
|---|---|
| 1 month (2024-11-21) | 4.79% |
| 3 months (2024-09-20) | -8.96% |
| 6 months (2024-06-21) | -29.67% |
| 1 year (2023-12-21) | -30.18% |
|---|---|
| 2 years (2022-12-21) | -3.23% |
| 3 years (2021-12-21) | 94.20% |
| 5 years (2019-12-20) | 14.02 |
Is Voyager Therapeutics stock undervalued or overvalued?
Valuing Voyager Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Voyager Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Voyager Therapeutics's P/E ratio
Voyager Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Voyager Therapeutics shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Voyager Therapeutics's EBITDA
Voyager Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.1 million.
The EBITDA is a measure of a Voyager Therapeutics's overall financial performance and is widely used to measure a its profitability.
Voyager Therapeutics financials
| Revenue TTM | $163.8 million |
|---|---|
| Gross profit TTM | $-19,857,000 |
| Return on assets TTM | 1.57% |
| Return on equity TTM | 10.22% |
| Profit margin | 15.8% |
| Book value | $6.06 |
| Market Capitalization | $316.3 million |
TTM: trailing 12 months
Voyager Therapeutics share dividends
We're not expecting Voyager Therapeutics to pay a dividend over the next 12 months.
Voyager Therapeutics share price volatility
Over the last 12 months, Voyager Therapeutics's shares have ranged in value from as little as $5.19 up to $11.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Voyager Therapeutics's is 0.889. This would suggest that Voyager Therapeutics's shares are less volatile than average (for this exchange).
Voyager Therapeutics overview
Voyager Therapeutics, Inc. , a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc.
Frequently asked questions
What percentage of Voyager Therapeutics is owned by insiders or institutions?Currently 16.981% of Voyager Therapeutics shares are held by insiders and 65.52% by institutions. How many people work for Voyager Therapeutics?
Latest data suggests 162 work at Voyager Therapeutics. When does the fiscal year end for Voyager Therapeutics?
Voyager Therapeutics's fiscal year ends in December. Where is Voyager Therapeutics based?
Voyager Therapeutics's address is: 75 Hayden Avenue, Lexington, MA, United States, 02421 What is Voyager Therapeutics's ISIN number?
Voyager Therapeutics's international securities identification number is: US92915B1061 What is Voyager Therapeutics's CUSIP number?
Voyager Therapeutics's Committee on Uniform Securities Identification Procedures number is: 92915B106
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question